Loading…

Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients

Multiple risk factors contribute to the allograft survival of patients who have cadaveric renal transplantation. A retrospective review of 19 such factors in 426 patients identified race, DR match, B + DR match, number of transplants, and preservation time to have a significant influence. The parame...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgery 1988-05, Vol.207 (5), p.538-548
Main Authors: DIETHELM, A. G, BLACKSTONE, E. H, NAFTEL, D. C, HUDSON, S. L, BARBER, W. H, DEIERHOI, M. H, BARGER, B. O, CURTIS, J. J, LUKE, R. G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c444t-a786381483d12ccbd608aabd6113c3bbaf17babc5b6091a7e0a1c033696232f03
cites
container_end_page 548
container_issue 5
container_start_page 538
container_title Annals of surgery
container_volume 207
creator DIETHELM, A. G
BLACKSTONE, E. H
NAFTEL, D. C
HUDSON, S. L
BARBER, W. H
DEIERHOI, M. H
BARGER, B. O
CURTIS, J. J
LUKE, R. G
description Multiple risk factors contribute to the allograft survival of patients who have cadaveric renal transplantation. A retrospective review of 19 such factors in 426 patients identified race, DR match, B + DR match, number of transplants, and preservation time to have a significant influence. The parametric analysis confirmed the effect to be primarily in the early phase, i.e., first 6 months. All patients received cyclosporine with other methods of immunosuppression resulting in an overall 1-year graft survival rate of 66%. The overall 1-year graft survival rate in the white race was 73% and in the black race was 57% (p = 0.002). Allograft survival and DR match showed white recipients with a 1 DR match to have 75% survival at 1 year compared with 57% in the black patient (p = 0.009). If HLA B + DR match was considered, the white recipient allograft survival increased to 76%, 84%, and 88% for 1, 2, and 3 match kidneys by parametric analysis. Patients receiving first grafts had better graft survival (68%) than those undergoing retransplantation (58%) (p = 0.05). Organ preservation less than 12 hours influenced allograft survival with a 78% 1-year survival rate compared with 63% for kidneys with 12-18 hours of preservation. Despite the benefits of B + DR typing, short preservation time, and first transplants to the white recipient, the allograft survival in the black recipient remained uninfluenced by these parameters.
doi_str_mv 10.1097/00000658-198805000-00008
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1493502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78252821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-a786381483d12ccbd608aabd6113c3bbaf17babc5b6091a7e0a1c033696232f03</originalsourceid><addsrcrecordid>eNpVUctO5DAQtBArGFg-AckHxC3gR-I4HJDQiN1FQuKye7Y6jgOGTBxsZyT-nh4YRqwvLVd1Vz-KEMrZBWdNfck2T1W64I3WrMJPsUH0HlnwSiDMS7ZPFgjJomykOCRHKT0zxkvN6gNyIIXWXOoFebpbTSFmGDONPr3QHmwOMdHQUxiG8BihzzTNce3XMFA_UgsdrF30lkY3IpQjjGkaUACyD-MVBZry3L1tFEqh6ISwG3P6SX70MCR3so3H5N-v27_LP8X9w--75c19YcuyzAXUWkmNY8qOC2vbTjENgIFzaWXbQs_rFlpbtYo1HGrHgFsmpWqUkKJn8phcf-pOc7tyncXeEQYzRb-C-GYCePM_M_on8xjWhuOdKiZQ4HwrEMPr7FI2K5-sG3BFF-Zkai3wwoJjov5MtDGkFF2_a8KZ2bhkvlwyO5c-II2lp9-H3BVubUH-bMtDsjD0eGPr0y6tVlqVUsp3xTycPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78252821</pqid></control><display><type>article</type><title>Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients</title><source>PubMed Central</source><creator>DIETHELM, A. G ; BLACKSTONE, E. H ; NAFTEL, D. C ; HUDSON, S. L ; BARBER, W. H ; DEIERHOI, M. H ; BARGER, B. O ; CURTIS, J. J ; LUKE, R. G</creator><creatorcontrib>DIETHELM, A. G ; BLACKSTONE, E. H ; NAFTEL, D. C ; HUDSON, S. L ; BARBER, W. H ; DEIERHOI, M. H ; BARGER, B. O ; CURTIS, J. J ; LUKE, R. G</creatorcontrib><description>Multiple risk factors contribute to the allograft survival of patients who have cadaveric renal transplantation. A retrospective review of 19 such factors in 426 patients identified race, DR match, B + DR match, number of transplants, and preservation time to have a significant influence. The parametric analysis confirmed the effect to be primarily in the early phase, i.e., first 6 months. All patients received cyclosporine with other methods of immunosuppression resulting in an overall 1-year graft survival rate of 66%. The overall 1-year graft survival rate in the white race was 73% and in the black race was 57% (p = 0.002). Allograft survival and DR match showed white recipients with a 1 DR match to have 75% survival at 1 year compared with 57% in the black patient (p = 0.009). If HLA B + DR match was considered, the white recipient allograft survival increased to 76%, 84%, and 88% for 1, 2, and 3 match kidneys by parametric analysis. Patients receiving first grafts had better graft survival (68%) than those undergoing retransplantation (58%) (p = 0.05). Organ preservation less than 12 hours influenced allograft survival with a 78% 1-year survival rate compared with 63% for kidneys with 12-18 hours of preservation. Despite the benefits of B + DR typing, short preservation time, and first transplants to the white recipient, the allograft survival in the black recipient remained uninfluenced by these parameters.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/00000658-198805000-00008</identifier><identifier>PMID: 3288138</identifier><identifier>CODEN: ANSUA5</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adolescent ; Adult ; African Continental Ancestry Group ; Aged ; Antibodies, Monoclonal - therapeutic use ; Biological and medical sciences ; Cadaver ; Child ; European Continental Ancestry Group ; Female ; Graft Rejection ; Graft Survival ; Histocompatibility Testing ; HLA Antigens - analysis ; HLA-B Antigens ; HLA-DR Antigens - analysis ; Humans ; Immunosuppression - methods ; Kidney - immunology ; Kidney Transplantation ; Male ; Medical sciences ; Middle Aged ; Organ Preservation ; Risk Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Time Factors ; Transplantation, Homologous</subject><ispartof>Annals of surgery, 1988-05, Vol.207 (5), p.538-548</ispartof><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-a786381483d12ccbd608aabd6113c3bbaf17babc5b6091a7e0a1c033696232f03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1493502/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1493502/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,309,310,314,727,780,784,789,790,885,23930,23931,25140,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7686433$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3288138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DIETHELM, A. G</creatorcontrib><creatorcontrib>BLACKSTONE, E. H</creatorcontrib><creatorcontrib>NAFTEL, D. C</creatorcontrib><creatorcontrib>HUDSON, S. L</creatorcontrib><creatorcontrib>BARBER, W. H</creatorcontrib><creatorcontrib>DEIERHOI, M. H</creatorcontrib><creatorcontrib>BARGER, B. O</creatorcontrib><creatorcontrib>CURTIS, J. J</creatorcontrib><creatorcontrib>LUKE, R. G</creatorcontrib><title>Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>Multiple risk factors contribute to the allograft survival of patients who have cadaveric renal transplantation. A retrospective review of 19 such factors in 426 patients identified race, DR match, B + DR match, number of transplants, and preservation time to have a significant influence. The parametric analysis confirmed the effect to be primarily in the early phase, i.e., first 6 months. All patients received cyclosporine with other methods of immunosuppression resulting in an overall 1-year graft survival rate of 66%. The overall 1-year graft survival rate in the white race was 73% and in the black race was 57% (p = 0.002). Allograft survival and DR match showed white recipients with a 1 DR match to have 75% survival at 1 year compared with 57% in the black patient (p = 0.009). If HLA B + DR match was considered, the white recipient allograft survival increased to 76%, 84%, and 88% for 1, 2, and 3 match kidneys by parametric analysis. Patients receiving first grafts had better graft survival (68%) than those undergoing retransplantation (58%) (p = 0.05). Organ preservation less than 12 hours influenced allograft survival with a 78% 1-year survival rate compared with 63% for kidneys with 12-18 hours of preservation. Despite the benefits of B + DR typing, short preservation time, and first transplants to the white recipient, the allograft survival in the black recipient remained uninfluenced by these parameters.</description><subject>Adolescent</subject><subject>Adult</subject><subject>African Continental Ancestry Group</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cadaver</subject><subject>Child</subject><subject>European Continental Ancestry Group</subject><subject>Female</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>Histocompatibility Testing</subject><subject>HLA Antigens - analysis</subject><subject>HLA-B Antigens</subject><subject>HLA-DR Antigens - analysis</subject><subject>Humans</subject><subject>Immunosuppression - methods</subject><subject>Kidney - immunology</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Organ Preservation</subject><subject>Risk Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Time Factors</subject><subject>Transplantation, Homologous</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNpVUctO5DAQtBArGFg-AckHxC3gR-I4HJDQiN1FQuKye7Y6jgOGTBxsZyT-nh4YRqwvLVd1Vz-KEMrZBWdNfck2T1W64I3WrMJPsUH0HlnwSiDMS7ZPFgjJomykOCRHKT0zxkvN6gNyIIXWXOoFebpbTSFmGDONPr3QHmwOMdHQUxiG8BihzzTNce3XMFA_UgsdrF30lkY3IpQjjGkaUACyD-MVBZry3L1tFEqh6ISwG3P6SX70MCR3so3H5N-v27_LP8X9w--75c19YcuyzAXUWkmNY8qOC2vbTjENgIFzaWXbQs_rFlpbtYo1HGrHgFsmpWqUkKJn8phcf-pOc7tyncXeEQYzRb-C-GYCePM_M_on8xjWhuOdKiZQ4HwrEMPr7FI2K5-sG3BFF-Zkai3wwoJjov5MtDGkFF2_a8KZ2bhkvlwyO5c-II2lp9-H3BVubUH-bMtDsjD0eGPr0y6tVlqVUsp3xTycPw</recordid><startdate>19880501</startdate><enddate>19880501</enddate><creator>DIETHELM, A. G</creator><creator>BLACKSTONE, E. H</creator><creator>NAFTEL, D. C</creator><creator>HUDSON, S. L</creator><creator>BARBER, W. H</creator><creator>DEIERHOI, M. H</creator><creator>BARGER, B. O</creator><creator>CURTIS, J. J</creator><creator>LUKE, R. G</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19880501</creationdate><title>Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients</title><author>DIETHELM, A. G ; BLACKSTONE, E. H ; NAFTEL, D. C ; HUDSON, S. L ; BARBER, W. H ; DEIERHOI, M. H ; BARGER, B. O ; CURTIS, J. J ; LUKE, R. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-a786381483d12ccbd608aabd6113c3bbaf17babc5b6091a7e0a1c033696232f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>African Continental Ancestry Group</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cadaver</topic><topic>Child</topic><topic>European Continental Ancestry Group</topic><topic>Female</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>Histocompatibility Testing</topic><topic>HLA Antigens - analysis</topic><topic>HLA-B Antigens</topic><topic>HLA-DR Antigens - analysis</topic><topic>Humans</topic><topic>Immunosuppression - methods</topic><topic>Kidney - immunology</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Organ Preservation</topic><topic>Risk Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Time Factors</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DIETHELM, A. G</creatorcontrib><creatorcontrib>BLACKSTONE, E. H</creatorcontrib><creatorcontrib>NAFTEL, D. C</creatorcontrib><creatorcontrib>HUDSON, S. L</creatorcontrib><creatorcontrib>BARBER, W. H</creatorcontrib><creatorcontrib>DEIERHOI, M. H</creatorcontrib><creatorcontrib>BARGER, B. O</creatorcontrib><creatorcontrib>CURTIS, J. J</creatorcontrib><creatorcontrib>LUKE, R. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DIETHELM, A. G</au><au>BLACKSTONE, E. H</au><au>NAFTEL, D. C</au><au>HUDSON, S. L</au><au>BARBER, W. H</au><au>DEIERHOI, M. H</au><au>BARGER, B. O</au><au>CURTIS, J. J</au><au>LUKE, R. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>1988-05-01</date><risdate>1988</risdate><volume>207</volume><issue>5</issue><spage>538</spage><epage>548</epage><pages>538-548</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><coden>ANSUA5</coden><abstract>Multiple risk factors contribute to the allograft survival of patients who have cadaveric renal transplantation. A retrospective review of 19 such factors in 426 patients identified race, DR match, B + DR match, number of transplants, and preservation time to have a significant influence. The parametric analysis confirmed the effect to be primarily in the early phase, i.e., first 6 months. All patients received cyclosporine with other methods of immunosuppression resulting in an overall 1-year graft survival rate of 66%. The overall 1-year graft survival rate in the white race was 73% and in the black race was 57% (p = 0.002). Allograft survival and DR match showed white recipients with a 1 DR match to have 75% survival at 1 year compared with 57% in the black patient (p = 0.009). If HLA B + DR match was considered, the white recipient allograft survival increased to 76%, 84%, and 88% for 1, 2, and 3 match kidneys by parametric analysis. Patients receiving first grafts had better graft survival (68%) than those undergoing retransplantation (58%) (p = 0.05). Organ preservation less than 12 hours influenced allograft survival with a 78% 1-year survival rate compared with 63% for kidneys with 12-18 hours of preservation. Despite the benefits of B + DR typing, short preservation time, and first transplants to the white recipient, the allograft survival in the black recipient remained uninfluenced by these parameters.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>3288138</pmid><doi>10.1097/00000658-198805000-00008</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4932
ispartof Annals of surgery, 1988-05, Vol.207 (5), p.538-548
issn 0003-4932
1528-1140
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1493502
source PubMed Central
subjects Adolescent
Adult
African Continental Ancestry Group
Aged
Antibodies, Monoclonal - therapeutic use
Biological and medical sciences
Cadaver
Child
European Continental Ancestry Group
Female
Graft Rejection
Graft Survival
Histocompatibility Testing
HLA Antigens - analysis
HLA-B Antigens
HLA-DR Antigens - analysis
Humans
Immunosuppression - methods
Kidney - immunology
Kidney Transplantation
Male
Medical sciences
Middle Aged
Organ Preservation
Risk Factors
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Time Factors
Transplantation, Homologous
title Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T09%3A33%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Important%20risk%20factors%20of%20allograft%20survival%20in%20cadaveric%20renal%20transplantation:%20a%20study%20of%20426%20patients&rft.jtitle=Annals%20of%20surgery&rft.au=DIETHELM,%20A.%20G&rft.date=1988-05-01&rft.volume=207&rft.issue=5&rft.spage=538&rft.epage=548&rft.pages=538-548&rft.issn=0003-4932&rft.eissn=1528-1140&rft.coden=ANSUA5&rft_id=info:doi/10.1097/00000658-198805000-00008&rft_dat=%3Cproquest_pubme%3E78252821%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c444t-a786381483d12ccbd608aabd6113c3bbaf17babc5b6091a7e0a1c033696232f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78252821&rft_id=info:pmid/3288138&rfr_iscdi=true